𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Historical Perspective on the Treatment Challenges of Low-Grade Non-Hodgkin’s Lymphoma

✍ Scribed by Fernando Cabanillas

Book ID
117822033
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
187 KB
Volume
44
Category
Article
ISSN
1532-8686

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment patterns in low-grade non-Hodg
Treatment patterns in low-grade non-Hodgkin's lymphomas: A single institution study
✍ Liesveld, Jane L. ;Raubertas, Richard F. ;Bennett, John M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Ninety-two cases of low-grade non-Hodgkin's lymphoma were examined retrospectively to assess to what extent treatment deferral is practiced at a single university hospital with a local referral base. Clinical characteristics of this patient group were also analyzed; 70% of these cases were of nodula

Treatment of low-grade non-Hodgkin's lym
Treatment of low-grade non-Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trial
✍ Dr. E. Lepage; C. Sebban; C. Gisselbrecht; B. Coiffier; J. L. Harousseau; P. A. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

From 1981 to 1984 a randomized clinical trial was conducted to evaluate the role of doxorubicin in low grade malignancy non-Hodgkin's lymphoma (NHL). One hundred and thirteen patients were treated by an induction regimen including cyclophosphamide 400 mg/m2 day I and 8, vincristine 1.4 mg/m2 day 1 a

Ifosfamide in the treatment of high-grad
Ifosfamide in the treatment of high-grade recurrent non-hodgkin's lymphomas
✍ Ian Magrath; Melissa Adde; John Sandlund; Vinay Jain 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

We report the results of two phase I1 trials of ifosfamide in very high risk patients with either partially responsive or recurrent non-Hodgkin's lymphomas. In the first study, in which patients were extremely heavily pretreated (50 per cent had received a very intensive salvage regimen containing v